Start for free
Start for free
Moderna logo

Moderna

North America, Massachusetts, United States, Cambridge

Description

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

Investor Profile

Moderna has made 6 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Series B (33%)
  • Post Ipo Equity (33%)
  • Debt Financing (17%)
  • Series Unknown (17%)

Country Focus

  • United States (67%)
  • Germany (17%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Health Care
  • Hedge Funds
  • Medical
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Moderna frequently co-invest with?

Bristol-Myers Squibb
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
BlackRock Private Equity Partners
BlackRock Private Equity Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
Deep Track Capital
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
BlackRock
BlackRock
North America, New York, United States, New York
Co-Investments: 1
Vanguard
Vanguard
North America, Pennsylvania, United States, Kelayres
Co-Investments: 1
Leaps by Bayer
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Co-Investments: 2
BlackRock Innovation Capital
BlackRock Innovation Capital
North America, New York, United States, New York
Co-Investments: 1
J.P. Morgan Asset Management
J.P. Morgan Asset Management
North America, New York, United States, New York
Co-Investments: 1
Bridgewater Associates
Bridgewater Associates
North America, Connecticut, United States, Westport
Co-Investments: 1

What are some of recent deals done by Moderna?

immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Post Ipo EquitySep 11, 2023
Generation Bio

Cambridge, Massachusetts, United States

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

BiotechnologyGeneticsHealth Care
Post Ipo EquityMar 23, 2023
Amount Raised: $76,000,000
Metagenomi

Emeryville, California, United States

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

Artificial Intelligence (AI)BiotechnologyMachine LearningTherapeutics
Series BJan 5, 2023
Amount Raised: $100,000,000
Metagenomi

Emeryville, California, United States

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

Artificial Intelligence (AI)BiotechnologyMachine LearningTherapeutics
Series BJan 25, 2022
Amount Raised: $175,000,000

Global hedge fund that invests in a variety of asset classes, including equities, fixed income, and commodities.

Hedge Funds
Debt FinancingJan 1, 2022
Amount Raised: $5,500,000
Onkaido Therapeutics

Cambridge, Massachusetts, United States

The Onkaido Therapeutics team is exploring how messenger RNA therapeutics™ can deliver novel oncology drugs to help patients.

BiotechnologyHealth CareOncologyTherapeutics
Series UnknownJan 14, 2014
Amount Raised: $20,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator